Can tyrosine kinase inhibitors be discontinued in patients with metastatic renal cell carcinoma and a complete response to treatment? A multicentre, retrospective analysis - Johannsen, M; Flörcken, A; Bex, A (Eur Urol, 2009)
(Epub 2008 Oct18)